ZMYND11 and glioblastoma: G34V/R mutations compromise ZMYND11 binding to the H3.3K36me3 peptide (Wen et al. 2014c); however, a role for ZMYND11 has not been shown to date in any of the pediatric glioblastoma models or in chondroblastoma or giant cell tumors of bone.